Clinical Impact of Sarcopenia Screening on Long-Term Mortality in Patients Undergoing Coronary Bypass Grafting.

ABSTRACT:

Background

Sarcopenia is an aging-related condition characterized by loss of skeletal muscle mass and is an indicator of subclinical atherosclerosis. The relationship between reduced muscle mass and long-term clinical outcomes in patients with advanced coronary artery disease who have undergone coronary artery bypass grafting (CABG) is not fully understood. This study is sought to evaluate the prognostic implications of sarcopenia screening in patients undergoing CABG.

Methods

A total of 2810 patients who underwent CABG were analysed and classified according to presence of reduced muscle mass. The skeletal muscle index (SMI) was calculated as L3 muscle area (cm²)/height (m)² on computed tomography. Reduced SMI was defined as SMI ≤ 45 cm²/m

SUBMITTER: Lee SH 

PROVIDER: S-EPMC11634471 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature